Finished Dosage Forms and Raw Materials for the Pharmaceutical and Food Industries.
We are a Brazilian multinational company founded in 1984, which develops, manufactures and commercializes raw materials and medicines.
In raw materials, we work with active pharmaceutical ingredients (APIs), pharmaceutical excipients and food ingredients. Recognized for our high level of quality, global technical support and compliance with the main international manufacturing standards, we currently commercialize our products in approximately 100 countries on all the continents.
In medicines, we develop and manufacture high quality products in the HIV, hepatitis and osteoporosis segments, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories.
Our strategy for expanding our pharmaceutical unit is to increase our presence in the international market through partnerships to export our medicines. We are also looking for strategic alliances with international partners of recognized quality, to license and commercialize innovative and established products in segments such as oncology and hematology in Brazil and Latin America.
Blanver develops, produces and incorporates quality and competitive innovative products in its portfolio, always seeking to promote people’s health, quality of life and wellbeing.
We currently have three manufacturing plants in Brazil, as well as branches in the United States and Europe.
To develop, manufacture and market innovative products with quality and competitiveness for people’s health and wellbeing.
To be among the 500 largest companies in Brazil, meeting shareholders’ profitability expectations.
- Respect for People
- Respect for Rules
- Result Oriented
- Quality Oriented
- Social Responsibility